{
  "id": 17377,
  "url": "https://www.medianama.com/2026/08/223-india-drug-regulator-not-adopted-ai-approvals",
  "title": "India’s drug regulator has not adopted AI for regulatory approvals: Govt",
  "summary": "In response to the AI use in drug approval query, J.P. Nadda said CDSCO continues to rely on scientific and technical review for regulatory decisions and the Subject Expert Committee examines clinical trial approvals. The post India’s drug regulator has not adopted AI for regulatory approvals: Govt appeared first on MEDIANAMA .",
  "authors": "Rohit Singh",
  "category": "news",
  "topics": "regulation,healthcare,biotech",
  "orgs": null,
  "regions": "india",
  "published_at": "2026-08-06T12:21:02.000Z",
  "fetched_at": "2026-08-07T05:10:58.501Z",
  "source_slug": "x-medianama-in",
  "source_name": "MediaNama (IN)",
  "source_homepage": "https://www.medianama.com",
  "ethics_ai_record_url": "https://ethics.ai/record/17377",
  "original_url": "https://www.medianama.com/2026/08/223-india-drug-regulator-not-adopted-ai-approvals",
  "evidence_status": "source-only",
  "attribution": "via ethics.ai"
}